480
Views
1
CrossRef citations to date
0
Altmetric
Review

Prevalence of RPGR-mutated X-linked retinitis pigmentosa among males

, , , &
Pages 581-588 | Received 06 May 2022, Accepted 24 Jul 2022, Published online: 25 Aug 2022

References

  • Cehajic Kapetanovic J, McClements ME, Martinez-Fernandez de la Camara C, MacLaren RE. Molecular strategies for RPGR gene therapy. Genes (Basel). 2019;10(9):674. doi:10.3390/genes10090674.
  • Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–809. doi:10.1016/S0140-6736(06)69740-7.
  • Tee JJL, Smith AJ, Hardcastle AJ, Michaelides M. RPGR-Associated retinopathy: Clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol. 2016;100(8):1022–27. doi:10.1136/bjophthalmol-2015-307698.
  • Sandberg MA, Rosner B, Weigel-DiFranco C, Dryja TP, Berson EL. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci. 2007;48(3):1298–304. doi:10.1167/iovs.06-0971.
  • Martinez-Fernandez De La Camara C, Nanda A, Salvetti AP, Fischer MD, MacLaren RE. Gene therapy for the treatment of X-linked retinitis pigmentosa. Expert Opin Orphan Drugs. 2018;6(3):167–77. doi:10.1080/21678707.2018.1444476.
  • Megaw RD, Soares DC, Af W. RPGR: Its role in photoreceptor physiology, human disease, and future therapies. Exp Eye Res. 2015;138:32–41. doi:10.1016/j.exer.2015.06.007.
  • Branham K, Othman M, Brumm M, Karoukis AJ, Atmaca-Sonmez P, Yashar BM, Schwartz SB, Stover NB, Trzupek K, Wheaton D, et al. Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci. 2012;53(13):8232–37. doi:10.1167/iovs.12-11025.
  • Breuer DK, Yashar BM, Filippova E, Hiriyanna S, Lyons RH, Mears AJ, Asaye B, Acar C, Vervoort R, Wright AF, et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet. 2002;70(6):1545–54. doi:10.1086/340848.
  • Churchill JD, Bowne SJ, Sullivan LS, Lewis RA, Wheaton DK, Birch DG, Branham KE, Heckenlively JR, Daiger SP. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013;54(2):1411–16. doi:10.1167/iovs.12-11541.
  • Neidhardt J, Glaus E, Lorenz B, Netzer C, Li Y, Schambeck M, Wittmer M, Feil S, Kirschner-Schwabe R, Rosenberg T, et al. Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis. 2008;14:1081–93.
  • Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick TH. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol. 1984;97(3):357–65. doi:10.1016/0002-9394(84)90636-6.
  • Prokisch H, Hartig M, Hellinger R, Meitinger T, Rosenberg T. A population-based epidemiological and genetic study of X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2007;48(9):4012–18. doi:10.1167/iovs.07-0071.
  • Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet. 1980;32(2):223–35.
  • Bundey S, Crews SJ. A study of retinitis pigmentosa in the City of Birmingham. I Prevalence. J Med Genet. 1984;21(6):417–20. doi:10.1136/jmg.21.6.417.
  • Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand Suppl. 2002;233:1–34. doi:10.1046/j.1395-3907.2002.00001.x.
  • Holtan JP, Selmer KK, Heimdal KR, Bragadóttir R. Inherited retinal disease in Norway - a characterization of current clinical and genetic knowledge. Acta Ophthalmol. 2020;98(3):286–95. doi:10.1111/aos.14218.
  • Nájera C, Millán JM, Beneyto M, Prieto F. Epidemiology of retinitis pigmentosa in the Valencian community (Spain). Genet Epidemiol. 1995;12(1):37–46. doi:10.1002/gepi.1370120105.
  • Peterlin B, Canki-Klain N, Morela V, Stirn B, Rainer S, Cerar V. Prevalence of retinitis pigmentosa in Slovenia. Clin Genet. 1992;42(3):122–23. doi:10.1111/j.1399-0004.1992.tb03222.x.
  • Ayuso C, Garcia-Sandoval B, Najera C, Valverde D, Carballo M, Antiñolo G. Retinitis pigmentosa in Spain. The Spanish multicentric and multidisciplinary group for research into retinitis pigmentosa. Clin Genet. 1995;48(3):120–22. doi:10.1111/j.1399-0004.1995.tb04069.x.
  • Berson EL, Rosner B, Simonoff E. Risk factors for genetic typing and detection in retinitis pigmentosa. Am J Ophthalmol. 1980;89(6):763–75. doi:10.1016/0002-9394(80)90163-4.
  • Dickinson P, Mulhall L. A survey of hereditary aspects of pigmentary retinal dystrophies. Aust N Z J Ophthalmol. 1989;17(3):247–56. doi:10.1111/j.1442-9071.1989.tb00528.x.
  • Testa F, Rossi S, Colucci R, Gallo B, Di Iorio V, della Corte M, Azzolini C, Melillo P, Simonelli F. Macular abnormalities in Italian patients with retinitis pigmentosa. Br J Ophthalmol. 2014;98(7):946–50. doi:10.1136/bjophthalmol-2013-304082.
  • Weisschuh N, Obermaier CD, Battke F, Bernd A, Kuehlewein L, Nasser F, Zobor D, Zrenner E, Weber E, Wissinger B, et al. Genetic architecture of inherited retinal degeneration in Germany: A large cohort study from a single diagnostic center over a 9-year period. Hum Mutat. 2020;41(9):1514–27. doi:10.1002/humu.24064.
  • Nirmalan PK, Krishnaiah S, Nutheti R, Shamanna BR, Rao GN, Thomas R. Consanguinity and eye diseases with a potential genetic etiology. Data from a prevalence study in Andhra Pradesh, India. Ophthalmic Epidemiol. 2006;13(1):7–13. doi:10.1080/09286580500473795.
  • Sen P, Bhargava A, George R, Ve Ramesh S, Hemamalini A, Prema R, Kumaramanickavel G, Vijaya L. Prevalence of retinitis pigmentosa in South Indian population aged above 40 years. Ophthalmic Epidemiol. 2008;15(4):279–81. doi:10.1080/09286580802105814.
  • Sharon D, Banin E. Nonsyndromic retinitis pigmentosa is highly prevalent in the Jerusalem region with a high frequency of founder mutations. Mol Vis. 2015;21:783–92.
  • Kar B, John S, Kumaramanickavel G. Retinitis pigmentosa in India: A genetic and segregation analysis. Clin Genet. 1995;47(2):75–79. doi:10.1111/j.1399-0004.1995.tb03927.x.
  • Vinchurkar MS, Sathye SM, Dikshit M. Retinitis pigmentosa genetics: A study in Indian population. Indian J Ophthalmol. 1996;44(2):77–82.
  • Rim TH, Park HW, Kim DW, Chung EJ. Four-year nationwide incidence of retinitis pigmentosa in South Korea: A population-based retrospective study from 2011 to 2014. BMJ Open. 2017;7(5):e015531. doi:10.1136/bmjopen-2016-015531.
  • Hayakawa M, Fujiki K, Kanai A, Matsumura M, Honda Y, Sakaue H, Tamai M, Sakuma T, Tokoro T, Yura T, et al. Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa. Jpn J Ophthalmol. 1997;41(1):1–6. doi:10.1016/s0021-5155(96)00018-4.
  • Liu X, Tao T, Zhao L, Li G, Yang L. Molecular diagnosis based on comprehensive genetic testing in 800 Chinese families with non-syndromic inherited retinal dystrophies. Clin Exp Ophthalmol. 2021;49(1):46–59. doi:10.1111/ceo.13875.
  • Birtel J, Gliem M, Mangold E, Müller PL, Holz FG, Neuhaus C, Lenzner S, Zahnleiter D, Betz C, Eisenberger T, et al. Next-generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa. PLoS One. 2018;13(12):e0207958. doi:10.1371/journal.pone.0207958.
  • Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, Makiyama Y, Morooka S, Matsuda F, Yoshimura N. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55(11):7369–75. doi:10.1167/iovs.14-15458.
  • Bader I, Brandau O, Achatz H, Apfelstedt-Sylla E, Hergersberg M, Lorenz B, Wissinger B, Wittwer B, Rudolph G, Meindl A, et al. X-Linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15. Invest Ophthalmol Vis Sci. 2003;44(4):1458–63. doi:10.1167/iovs.02-0605.
  • Bocquet B, Lacroux A, Surget M-O, Baudoin C, Marquette V, Manes G, Hebrard M, Sénéchal A, Delettre C, Roux A-F, et al. Relative frequencies of inherited retinal dystrophies and optic neuropathies in Southern France: Assessment of 21-year data management. Ophthalmic Epidemiol. 2013;20(1):13–25. doi:10.3109/09286586.2012.737890.
  • Dan H, Huang X, Xing Y, Shen Y. Application of targeted panel sequencing and whole exome sequencing for 76 Chinese families with retinitis pigmentosa. Mol Genet Genomic Med. 2020;8(3):e1131. doi:10.1002/mgg3.1131.
  • Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, Inai C, Iwasaki Y, Kumano M, Murakami Y, et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet. 2019;56(10):662–70. doi:10.1136/jmedgenet-2018-105691.
  • Kurata K, Hosono K, Hayashi T, Mizobuchi K, Katagiri S, Miyamichi D, Nishina S, Sato M, Azuma N, Nakano T, et al. X-linked retinitis pigmentosa in Japan: Clinical and genetic findings in male patients and female carriers. Int J Mol Sci. 2019;20(6):E1518. doi:10.3390/ijms20061518.
  • Motta FL, Martin RP, Filippelli-Silva R, Salles MV, Sallum JMF. Relative frequency of inherited retinal dystrophies in Brazil. Sci Rep. 2018;8(1):15939. doi:10.1038/s41598-018-34380-0.
  • Pelletier V, Jambou M, Delphin N, Zinovieva E, Stum M, Gigarel N, Dollfus H, Hamel C, Toutain A, Dufier J-L, et al. Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: Genotype-phenotype correlations and impact on genetic counseling. Hum Mutat. 2007;28(1):81–91. doi:10.1002/humu.20417.
  • Perea-Romero I, Gordo G, Iancu IF, Del Pozo-Valero M, Almoguera B, Blanco-Kelly F, Carreño E, Jimenez-Rolando B, Lopez-Rodriguez R, Lorda-Sanchez I, et al. Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications. Sci Rep. 2021;11(1):1526. doi:10.1038/s41598-021-81093-y.
  • Pontikos N, Arno G, Jurkute N, Schiff E, Ba-Abbad R, Malka S, Gimenez A, Georgiou M, Wright G, Armengol M, et al. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology. 2020;127(10):1384–94. doi:10.1016/j.ophtha.2020.04.008.
  • Rodríguez-Muñoz A, Aller E, Jaijo T, González-García E, Cabrera-Peset A, Gallego-Pinazo R, Udaondo P, Salom D, García-García G, Millán JM. Expanding the clinical and molecular heterogeneity of nonsyndromic inherited retinal dystrophies. J Mol Diagn. 2020;22(4):532–43. doi:10.1016/j.jmoldx.2020.01.003.
  • Sharon D, Sandberg MA, Rabe VW, Stillberger M, Dryja TP, Berson EL. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet. 2003;73(5):1131–46. doi:10.1086/379379.
  • Yang L, Yin X, Feng L, You D, Wu L, Chen N, Li A, Li G, Ma Z, Janecke AR. Novel mutations of RPGR in Chinese retinitis pigmentosa patients and the genotype-phenotype correlation. PLoS One. 2014;9(1):e85752. doi:10.1371/journal.pone.0085752.
  • Chiang JPW, Lamey TM, Wang NK, Duan J, Zhou W, McLaren TL, Thompson JA, Ruddle J, De Roach JN. Development of high-throughput clinical testing of RPGR ORF15 using a large inherited retinal dystrophy cohort. Invest Ophthalmol Vis Sci. 2018;59(11):4434–40. doi:10.1167/iovs.18-24555.
  • Comander J, Weigel-DiFranco C, Sandberg MA, Berson EL. Visual function in carriers of X-linked retinitis pigmentosa. Ophthalmology. 2015;122(9):1899–906. doi:10.1016/j.ophtha.2015.05.039.
  • Fahim AT, Sullivan LS, Bowne SJ, Jones KD, Wheaton DKH, Khan NW, Heckenlively JR, Jayasundera KT, Branham KH, Andrews CA, et al. X-Chromosome Inactivation is a biomarker of clinical severity in female carriers of RPGR-associated X-linked retinitis pigmentosa. Ophthalmol Retina. 2020;4(5):510–20. doi:10.1016/j.oret.2019.11.010.
  • Talib M, van Schooneveld MJ, Van Cauwenbergh C, Wijnholds J, Ten Brink JB, Florijn RJ, Schalij-Delfos NE, Dagnelie G, van Genderen MM, De Baere E, et al. The spectrum of structural and functional abnormalities in female carriers of pathogenic variants in the RPGR gene. Invest Ophthalmol Vis Sci. 2018;59(10):4123–33. doi:10.1167/iovs.17-23453.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.